In patients with type 2 diabetes, serum PCT seems to be better correlated with cardiovascular risk than serum highly sensitive C-reactive protein which has previously been shown to be associated with cardiovascular diseases. This evidence concerns the gene CRP and type 2 diabetes mellitus.